Reversible fibroadenomatous mammary hyperplasia in male and female New Zealand white rabbits associated with cyclosporine A administration.
All male and female New Zealand white rabbits in a limbal cell graft study developed marked generalized mammary gland hypertrophy. Postprocedural medications included ophthalmic 0.1% dexamethasone, ophthalmic 0.5% cyclosporine, and subcutaneous cyclosporine A. Cytologic examination revealed epithelial clusters with minimal malignant criteria. On histologic evaluation, there was diffuse glandular hyperplasia with mild cellular atypia and ductal ectasia separated by abundant hypercellular fibrous stroma, consistent with fibroadenomatous mammary gland hyperplasia. The hyperplasia resolved within 2 weeks of cessation of cyclosporine, and at necropsy identifiable mammary masses were not found. Very little has been reported about the use of cyclosporine in laboratory rabbits and its association with development of mammary gland hyperplasia. This is the first report in which administration of cyclosporine to male and female rabbits at a dose as low as 5 mg/kg/day induced benign fibroadenomatous mammary gland hyperplasia. This change regressed after cessation of the drug.
Krimer
P M
PM
Athens Veterinary Diagnostic Laboratory, University of Georgia College of Veterinary Medicine, Athens, GA 30602, USA. krimerp@uga.edu
Harvey
S B
SB
Blas-Machado
U
U
Lauderdale
J D
JD
Moore
P A
PA
D000232:Adenofibroma / Q000139:chemically induced / Q000473:pathology / Q000662:veterinary*; D000818:Animals; D016572:Cyclosporine / Q000009:adverse effects*; D005260:Female; D006984:Hypertrophy / Q000139:chemically induced / Q000473:pathology / Q000662:veterinary*; D007166:Immunosuppressive Agents / Q000009:adverse effects; D008297:Male; D008321:Mammary Glands, Animal / Q000187:drug effects* / Q000473:pathology; D011817:Rabbits
D007166:Immunosuppressive Agents; D016572:Cyclosporine